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ABSTRACT 
 Understanding the control of piscine fatty acid metabolism is important for determining 
the nutritional requirements of fish, and hence for the production of optimal aquaculture diets. 
The regulation and expression of carnitine palmitoyltransferase 1 (CPT1; EC No 2.3.1.21) are 
critical processes in the control fatty acid metabolism, and here we report a cDNA from gilthead 
sea bream (Sparus aurata) which encodes a protein with high identity to vertebrate CPT1. This 
sea bream CPT1 mRNA is predominantly expressed in skeletal and cardiac muscle, with little 
expression in other tissues. Phylogenetic analysis of other vertebrate CPT1 sequences show that 
fish genomes contain a single gene related to mammalian CPT1B, and a further two multi-gene 
families related to mammalian CPT1A. Genes related to mammalian CPT1C are absent in fish. 
Therefore, based on both functional and evolutionary orthology to mammalian CPT1B, the sea 
bream CPT1 reported here is a CPT1B isoform. Sea bream CPT1B mRNA expression 
progressively decreases in heart and muscle up to 12 hours after last feeding, but returns to 
initial, non-fasted levels after 72 hours. In contrast, in liver non-fasted expression is low, but 
strongly increases at 24 and 72 hours after last feeding. In white muscle and liver, CPT1B 
mRNA expression is highly correlated with the expression of peroxisomal proliferator-activated 
receptor  (PPAR).Thus fatty acid metabolism by CPT1B and its control by PPARs is similar 
in fish and mammals, but multiple genes for CPT1A-like proteins in fish also suggest different 
and more complex pathways of lipid utilisation than in mammals. 
 
1. INTRODUCTION 
 
Carnitine palmitoyltransferase 1 (CPT1, EC2.3.1.21) along with carnitine palmitoyltransferase 2 
(CPT2) forms the mitochondrial carnitine palmitolyltransferase system, which mediates the 
uptake of long-chain fatty acids to the mitochondrion (McGarry and Brown, 1997). CPT1 is 
anchored in the outer mitochondrial membrane and catalyzes the transfer of fatty acyl groups 
from coenzyme A to carnitine. Acylcarnitine transverses the inner mitochondrial membrane by 
means of a specific translocase and fatty acyl-CoAs within the matrix are regenerated by CPT2. 
CPT1, by virtue of its inhibition by malonyl-CoA is the main regulatory point in fatty acid β-
oxidation with increasing levels of malonyl-CoA favouring fatty acid utilisation in biosynthesis 
This process is central in maintaining an effective fuel “cross talk”, which according to the 
energy needs of the organism can lead to either catabolism or biosynthesis of fatty acids in a 
variety of tissues such as the liver, heart, and the skeletal muscle (Britton et al., 1995). 
Consequently, the study of CPT1 in mammals has gathered considerable interest as one 
potential target for the pharmacological 
control of fatty acid oxidation. 
In mammals, CPT1 is encoded by three genes, one being expressed predominantly in 
the liver (CPT1A) and the second (CPT1B) in the skeletal muscle (Esser et al., 1996). The 
muscle and liver isoforms are 62% identical in amino acid sequence and exhibit different 
sensitivity to malonyl-CoA inhibition (Treber et al., 2003). A third more distantly related 
isoform of the enzyme (CPT1C) which is restricted to the central nervous system and functions 
in the control of whole-body glucose homeostasis  has been recently described in mammalian 
species (Price et al., 2002, Gao et al., 2009).  
Further to differences in regulation at the catalytic level, the mammalian CPT1 isoforms 
are also differentially regulated at the gene level. Thus, CPT1A is primarily hormonally 
regulated, while CPT1B is primarily fuel-regulated (Cook et al., 2001). It is currently well 
established that fatty acids, peroxisome proliferators, as well as physiological conditions such as 
feeding and fasting affect the expression of the CPT1 genes (Yu et al., 1998, Brandt et al., 
1998). Key mediators of these processes are the peroxisome proliferator-activated receptors, 
PPAR (Baldán et al., 2004, Gilde et al., 2003, Mescaró et al., 1998), which have been described 
as transcription factors at the crossroads of diet and hormonal signalling (Desvergne et al., 
1998). 
The regulation of fatty acid and lipid metabolism at the gene level has been poorly 
studied in fish species, despite the fact that problems related to fatty acid metabolism are of 
primary importance to modern aquaculture practices (Leaver et al., 2008). Molecular studies 
concerning CPT1 expression in fish are presently limited to rainbow trout (Oncorhynchus 
mykiss), i.e. the species in which a CPT1 encoding sequence was first identified (Gutières et al., 
2003). Although it was originally proposed that trout expressed a single CPT1 gene 
corresponding to the mammalian liver isoform (Gutières et al., 2003), further studies of CPT1 
sensitivity for malonyl-CoA, coupled to determination of relative mRNA expression levels, in 
the tissues of thefish suggested the presence of additional isoform(s) (Morash et al.,2008). 
Indeed, another three CPT1-like sequences have recently been identified in trout, and their 
expression has subsequently been studied in response to nutritional and hormonal stimuli, and in 
relation to the expression of other genes encoding enzymes involved in fatty acid metabolism, 
including two trout PPAR isotypes (Kolditz et al., 2008; Lansard et al., 2009; Morash et al., 
2009; Plagnes-Juan et al., 2008; Polakof et al., 2010). However, these four trout isoforms have 
been arbitrarily termed CPT1a-d (Kolditz et al., 2008), a nomenclature not based on 
functional/evolutionary orthology to the mammalian CPT1isoforms. Therefore, a more 
systematic study of the evolutionary relationship of the piscine CPT1 isoforms to their 
mammalian counterpartsis needed. This, in turn, will aid the further understanding of 
CPT1function in fish, specifically regarding the identification of factors that are involved in its 
regulation, at both the gene and enzyme levels. 
Herein, we describe the identification and molecular characterization of a cDNA from 
the muscle tissue of an important aquaculture species, gilthead sea bream (Sparus aurata, sea 
bream hereafter), that encodes a protein with high similarity to CPT1 proteins from other 
species. By employing phylogenetic and tissue mRNA expression analyses we show that the 
deduced sea bream protein is likely to be the muscle CPT1 isoform (CPT1B). In addition, by 
utilising available fish genome data, we aimed to elucidate the evolutionary relationships 
amongst fish and the better chracterised mammalian CPT1 isoforms. Accordingly, we show that 
fish species contain a single CPT1B-like gene and multiple genes for CPT1A-like proteins. 
Furthermore, we test the hypothesis that the expression of sea bream CPT1B is regulated at the 
mRNA level depending on the prandial state of the fish, and is related to PPAR mRNA levels. 
 
2. MATERIAL AND METHODS 
 
2.1 Animals 
 Sea bream (S. aurata, Sparidae, Percomorpha,) were obtained from farmed stock 
(Interfish, Larimna, Greece). The fish were maintained in recirculating sea water in the indoor 
facility of the Fisheries Research Institute under natural photoperiod and constant water 
temperature (19–20 °C) conditions for approximately eight months. Prior to use, fish were fed a 
commercial diet (Excel 1°, Skretting) containing 20% 
fat, 48% protein. Sea bream is a protandrous species undergoing sex reversal after the second 
year of their lives. The fish used in this study aged 10 months and therefore were all male. 
Before sampling, fish were anaesthetized and killed by decapitation. Unless otherwise noted, 
fish were sampled at 24 h following last feeding. 
 
2.2 RNA isolation and synthesis of cDNA 
Total RNA from sea bream tissues, i.e. brain, liver, intestinal (proximal to cecum), gills, 
heart, red muscle, white muscle, and mesenteral adipose tissue, was extracted with the RNeasy 
tissue kit (Qiagen) according to the manufacturers instructions. One microgram of total red 
muscle RNA was used for reverse transcription with the Expand Reverse Transcriptase (Roche 
Applied Science) and an oligo-dT primer. Two microlitres of the cDNA thus obtained were 
used as template for PCR with the forward primer CPT5’F and the reverse primer CPT5’R1 
(0.25 µM, final concentration).  Both of these primers were designed according to a rainbow 
trout CPT1 cDNA sequence (GenBank access. no. AF327058). In addition to the above, PCR 
conditions included 1.5 units of Pfusion DNA polymerase (Finnzymes) and dNTPs (0.2 µM, 
final concentration) in a final volume of 50 µl. The cycler program and primer sequences are 
given in Table 1. The resulting 1350 bp fragment, which encoded the 450 amino-terminal 
residues including the initiation methionine of the sea bream CPT1, was ligated into the PCR4-
TOPO vector (Invitrogen) and was propagated as a plasmid insert for further analyses. 
  
2.3 Rapid amplification of the 3’ cDNA end (3’-RACE) 
The sequences encoding the carboxy-terminus of CPT1 were obtained through 3’-rapid 
amplification of cDNA ends PCR (3’-RACE) using a commercial kit (5’, 3’ RACE kit, Roche 
Applied Science) on cDNA synthesized with the oligo-dT anchor primer provided by the kit  
and the gene-specific primer CPTF3’3. The primer sequences and thermocycling program are 
given in Table 1. The resulting 1124 bp amplification product, encoding the 363 carboxy-
terminal residues of the protein, was inserted into the pCR-Script Amp SK(+) vector 
(Stratagene) for further analyses. 
 
2.4 Deduced protein sequence and phylogenetic analyses 
Hydrophobicity regions and/or potential transmembrane helices within the deduced 
protein sequence of the sea bream CPT1 were calculated with the algorithms available in the 
OMIGA 2.0 software package (Accelerys). Functional motifs were identified by a PROSITE 
search (http://au.expasy.org/prosite). For phylogenetic tree construction, the amino acid 
sequences of the sea bream protein along with the CPT1 isoforms from other species were 
aligned using the OMIGA 2.0 software package. Amino acid sequences for pufferfish 
(Tetraodon nigroviridus) and zebrafish CPT1 proteins were obtained from gene sequences 
predicted from Ensembl/Genbank genome databases. The alignment file was used to construct 
neighboring-joining trees using the MEGA 2 (Kumar et al., 2001) and/or the PAUP 4b 
(Swofford, 2000) software packages. The trees were tested for robustness by “bootstrapping” 
through 1000 iterations. 
 
Table 1. Primer sequences and PCR conditions for cloning and expression analysis  
 
Primer 
Pairs Gene Sequence Application 
Amplification 
Conditions 
CPT5’F 
CPT5’R1 CPT1 
5’-GATGGCAGAGGCACATCAGG 
5’-TGGAGCACATAGGAACGGTCC RT-PCR 
a) 
94oC-4 min [(94oC-30 
sec / 56oC-30 sec / 72oC-
1 min) 10 cycles + 
(94oC-30 sec / 55oC-30 
sec / 72oC-1 min + 5 sec 
/ cycle) 25 cycles] / 
72oC-7 min   
CPTF3’3 
Anchor b) CPT1 
5’-TGCCATTGAGTCAGCTGCCTTCTTC 
5’- GACCACGCGTATCGATGTCGAC 3’-RACE 
94oC-4 min (94oC-30 sec 
/ 56oC-30 sec / 72oC-90 
sec) 35 cycles / 72oC-7 
min   
QSaCPT1BF 
QSaCPT1BR CPT1 
5’-CAAGCCCCGACACAGACTCATACC 
5’-CCCATTTCCCAGCTGCGTTATTTT Q-PCR 
c)
 
95oC-10 min (95oC-30 
sec / 60oC-1 min) 45 
cycles d) 
QSaPPARaF 
QSaPPARaR PPARα 
5’-
CTGAATGATCAGGTGACTCTCTTGAAG 
5’-
CCTGGGCGATCTCCGCAGCAGATAATG 
Q-PCR Idem 
QSaPPARbF 
QSaPPARbR PPARβ 
5’-TGCGGTCAAGTTCAATGCTCT 
5’-GACTCTGCTCCACCTGCTTCA Q-PCR Idem 
QSaPPARgF 
QSaPPARgR PPARγ 
5’-ATGATGGCACCTCTGATGAACAA 
5’-TGAGATAATGACAGCCAGAAACA Q-PCR Idem 
QSaEF1aF 
QSaEF1aR EF1a 
5’-CATGGTTGTGGAGCCCTTCT 
5’-TCCTGCACGACCATTCATTTC Q-PCR Idem 
 
a)
 Reverse transcription followed by PCR 
b)
 5’/3’ RACE kit (Roche Applied Science) Anchor primer  
c)
 Quantitative real-time PCR 
d) Followed by generation of a melt curve by measuring fluorescence during heating from 55oC 
to 95oC 
 
2.5 Riboprobes and RNase protection assay  
The presence of CPT1B transcripts in different sea bream tissues was examined by the 
RNase protection assay using a commercial kit (RNase protection kit, Roche Applied Science). 
For the CPT1 riboprobe, the 5’-end fragment of the CPT1 cDNA in the PCR4-TOPO vector 
(see above) was digested with the Bam HI and Eco RI restriction endonucleases and the 
resulting 260 bp fragment (positions 1091-1350 of the cDNA) was inserted into the 
corresponding sites of pBluescript II KS (Stratagene). The recombinant plasmid was digested 
with Not I and the antisense riboprobe was synthesized by T3 polymerase transcription 
(Promega). The synthesis of the sea bream β-actin riboprobe has been previously described 
(Leaver et al., 2005). Riboprobes were labeled with [α-32P]CTP (800 Ci/mmol, Amersham 
Biosciences Europe) and the RNase protection assay was performed as previously described 
(Boukouvala et al., 2004, Leaver et al., 2005) on 8 µg of total RNA from each tissue sample. 
The protected fragments were separated on a 6% polyacrylamide gel containing 7M urea. 
Signals were visualized by autoradiography. 
  
2.6 Quantitative real-time PCR (Q-PCR) 
Extraction of total RNA from fish tissues and first strand cDNA synthesis were 
performed as described above. The cDNA synthesis reactions were diluted to 200µl in water. Q-
PCR reactions (20 µl) contained 10µl of the Briliant II SYBR Green QPCR Master Mix 
(Stratagene), 2 µl of cDNA, and 75 nM of each primer. No-template control reactions were 
included for each target gene. PCR was performed in 96-well plates in a Stratagene (Agilent) 
Mx3000P thermocycler. The 133 bp fragment of CPT1B cDNA (positions 2208-2348 of cDNA, 
GenBank DQ866821) was amplified with primers QSaCPT1BF  and QSaCPT1BR; the 265 bp 
fragment of sea bream PPARα cDNA (positions 1028-1293 of cDNA, GenBank AY590299) 
was amplified with primers QSaPPARaF and QSaPPARaR; the 119 bp fragment of sea bream 
PPARβ cDNA (positions 1393-1511 of cDNA, GenBank AY590301) was amplified with 
primers QSaPPARbF and QSaPPARbR; the 195 bp fragment of sea bream PPARγ cDNA 
(positions 1387-1582 of cDNA, GenBank AY590304) was amplified using primers 
QSaPPARgF and QSaPPARgR. The relative expression of PPAR and CPT1B genes was 
calculated with the “delta-delta Ct” method (Pfaffl, 2001), where elongation factor 1a (EF1a) 
was used as a reference gene. The 166 bp fragment of sea bream EF1a cDNA (positions 1234-
1407 of cDNA, GenBank AF184170) was amplified with primers QSaEF1aF and QSaEF1aR. 
The thermocycling program and primer sequences used in this analysis are given in Table 1. All 
reactions were performed in duplicates and each reaction was verified to contain a single 
product of the correct size by agarose gel electrophoresis. Amplification of the correct targets 
was further confirmed by DNA sequencing.  Statistical differences between samples were 
determined by one-way ANOVA, followed by the Tukey post test, using the STATISTICA 7 
(StatSoft) software package. 
 
2.7 Post-prandial experiments 
Fish aged 10 months and of average weight 200 ± 50 g were kept unfed for a 24 h 
period, at the end of which they were allowed to feed to satiation. One hour after feeding five 
fish were removed and tissues (heart, red muscle, white muscle, and liver) were excised for 
RNA extraction, as described above. The same procedure was followed for fish that were 
removed from the tank at 3, 5, 8, 12, 24, and 72 h after feeding. The progression of food through 
the digestive tract (stomach, intestine, and rectum) was recorded at each sampling time point 
and was used to select fish for the mRNA expression analysis. Under the conditions of this 
experiment, food evacuation started as early as 3 h post-feeding (presence of digested material 
in the rectum) and it was completed between the 24 and 72 h time points (digestive tract was 
completely empty).   
 
3. RESULTS  
 
3.1 Cloning of the CPT1 cDNA and analysis of the deduced protein sequence. 
The previous identification of a partial cDNA encoding the amino-terminus of a CPT1 
protein from rainbow trout (Gutières et al., 2003) demonstrated a high degree of sequence 
conservation between mammalian and teleost CPT1 at both the nucleotide and amino acid 
levels. Thus, oligonucleotide primers were designed with sequences corresponding to regions of 
high identity between the reported trout and mammalian cDNA sequences. At the time that this 
work was initiated the complete coding sequence of the trout CPT1 was not known. Therefore, 
we initially performed reverse transcription coupled to PCR (RT-PCR) on total RNA isolated 
from sea bream red muscle with a forward primer encompassing the presumed initiation codon 
along with a reverse primer corresponding to nucleotides 1546-1566 of the trout cDNA. 
Through this approach, a 1350 bp amplicon was obtained, which upon sequence analysis was 
found to encode the 450 amino-terminal residues of the sea bream CPT1. To identify the 
sequences encoding the carboxy-terminus of the protein, a gene-specific primer was designed 
(nt positions 1224-1248 of the sea bream cDNA) and was used in 3’–RACE PCR. This 
approach resulted in the amplification of an 1124 bp fragment that included the sequences 
encoding the 367 carboxy-terminal residues of the protein, as well as 16 bp of 3’-untranslated 
sequence. 
The complete deduced amino acid sequence of the sea bream CPT1 is shown in Fig. 1. 
The protein contains 776 residues and exhibits extended sequence homology with CPT1 
proteins from other species. Within this protein, hydrophobicity analysis predicts the presence 
of two transmembrane helices spanning residues 50–80 and 100–136. Further, a functional 
motifs search predicts the presence of two carnitine acyltransferase sites within residues 171–
186 and 449–476, two potential asparagine glycosylation sites at residues 312 and 367, as well 
as a potential tyrosine phosphorylation site at residue 191. Most of these residues are conserved 
in the proteins from other species (Fig. 1). 
 
3.2 Phylogenetic analysis of the sea bream CPT1. 
In mammals, the liver and the heart/skeletal muscle CPT1 isoforms share 62% identical 
residues. The alignment of Fig. 1 shows that the sea bream CPT1 shares almost equal levels of 
identity with the human liver and muscle isoforms, 67 and 66%, respectively, while it shares 
80% identical residues with the previously reported trout protein (Gutières et al., 2003). 
Although this information provides strong evidence that the sea bream protein is homologous to 
that of trout, it does not allow conclusions on whether, in either species, it represents the liver or 
the muscle isoform. We addressed this question by constructing phylogenetic trees where the 
sea bream protein sequence was compared with CPT1 sequences from a variety of species. 
Attempts were made to include only apparent full length polypeptides in these comparisons and, 
thus, sequences were derived initially from BLAST searches of GenBank against sea bream 
CPT1, followed by prediction of full length sequences from Danio rerio (zebrafish) and 
Takifugu rubripes (pufferfish) genomic data. The consensus neighbouring-joining tree depicted 
in Fig. 2 demonstrates that the sea bream sequence, along with the originally reported trout 
sequence (GenBank:AF327058, Gutières et al., 2003), clusters robustly with the mammalian 
CPT1B sequences. Similarly, the robust bootstrap value at the node of the CPT cluster 
containing human CPT1A, which includes two zebrafish sequences (GenBank:AL929208 and 
XM_683391), one trout sequence (GenBank:AJ691768), and a pufferfish polypeptide derived 
from genomic sequence, along with the Xenopus and chick sequences, show that fish also 
possess representatives of the CPT1A family, distinct from CPT1B. This tree also demonstrates 
that the mammalian CPT1C isoform is distantly related to either the A or B isoforms and forms 
a distinct clade. No fish sequences were positioned within the CPT1C clade. It is also clear from 
this phylogeny that fish possess a further CPT1 family, shown by the distinct clustering of two 
genes predicted from each of the zebrafish and pufferfish genomes and a trout cDNA 
(GenBank:AJ620356). There are no mammalian genes in this family and its position in the 
phylogenetic tree indicates that it may be a subfamily of CPT1A.  
 Sa CPT I  MAEAHQAVGFQFTVRPDGVDLKLSQEVIKNIYLSGVTAWKKRAIQFKNGVLAGVYPASPS   60 
Om CPT I  MAEAHQAVGFQFTVTPDGIDLHLSRE.....................NGILTGVYPASPS 
Hs CPT IA MAEAHQAVAFQFTVTPDGIDLRLSHEALRQIYLSGLHSWKKKFIRFKNGIITGVYPASPS 
Hs CPT IB MAEAHQAVAFQFTVTPDGVDFRLSREALKHVYLSGINSWKKRLIRIKNGILRGVYPGSPT 
Sa CPT I  SWLIVVIAMMSSLYIRVDPSLGMIDAIKENLPHRDYLSA..QTRAVLSAILFATGLWLFL  118 
Om CPT I  SLLIVVITIMSTIYARIDPSLGMIDTIKRTMSVSGYMTV..QTQTVLSAILFSTGLWLSL 
Hs CPT IA SWLIVVVGVMTTMYAKIDPSLGIIAKINRTLETANCMSS..QTKNVVSGVLFGTGLWVAL 
Hs CPT IB SWLVVIMATVGSSFCNVDISLGLVSCIQRCLPQGCGPYQTPQTRALLSMAIFSTGVWVTG 
Sa CPT I  IYLLRYTLKALLSYHGWIFESHGKMSTSTKLWLSLVKMFSGRRPLLYSFQASLPRLPVPS  178 
Om CPT I  ILMLRYILKALLSYHAWIFESHGKISFCTKLWLSLVKMLSGRRPLLYSFQTSLPRLPVPS 
Hs CPT IA IVTMRYSLKVLLSYHGWMFTEHGKMSRATKIWMGMVKIFSGRKPMLYSFQTSLPRLPVPA 
Hs CPT IB IFFFRQTLKLLLCYHGWMFEMHGKTSNLTRIWAMCIRLLSSRHPMLYSFQTSLPKLPVPR 
Sa CPT I  VDDTIQRYLESVRPLLDTKQYNQMEILANDFKESKAAQLQRYLILKSWWATNYVSDWWEE  238 
Om CPT I  VDDTITRYLESVRPLLDDEQYNQMEVVANDFKKDQAPKLQKYLILKSWWATNYVSDWWEE 
Hs CPT IA VKDTVNRYLQSVRPLMKEEDFKRMTALAQDFAVGLGPRLQWYLKLKSWWATNYVSDWWEE 
Hs CPT IB VSATIQRYLESVRPLLDDEEYYRMELLAKEFQDKTAPRLQKYLVLKSWWASNYVSDWWEE 
Sa CPT I  YIYLRSRSPIMVNSNFYIMDLLYMTPTHRQAARAGNVVHAMLQYRRKLERGEHAPLRALG  298 
Om CPT I  YFYLRGRSPIMVNSNFYSMDLLYVTPTHRQAARAGNVVHAMLQYRRKLERGEHAPLRALG 
Hs CPT IA YIYLRGRGPLMVNSNYYAMDLLYILPTHIQAARAGNAIHAILLYRRKLDREEIKPIRLLG 
Hs CPT IB YIYLRGRSPLMVNSNYYVMDLVLIKNTDVQAARLGNIIHAMIMYRRKLDREEIKPVMALG 
Sa CPT I  .TVPMCSTQMERMFNTTRIPGIETDVVQHLTDRKHLLVYHKGRFFQVWLYTGGRHLLPGE  357 
Om CPT I  .VVPMCSYQMERMFNTTRIPGIETDFVQHLSDRKHLVVYHKGCFFKVWLYYGGRHLWPSE 
Hs CPT IA STIPLCSAQWERMFNTSRIPGEETDTIQHMRDSKHIVVYHRGRYFKVWLYHDGRLLKPRE 
Hs CPT IB .IVPMCSYQMERMFNTTRIPGKDTDVLQHLSDSRHVAVYHKGRFFKLWLYEGARLLKPQD 
 
Sa CPT I  LETQFQRILNDTSEPQPGELKLAALTAGSRVPWARARIKYFGQGVNKASLDAIESAAFFL  417 
Om CPT I  LETQFQRILDDTTKPQPGELKLAAHTAGKRVPWARARLKYFSQGVNKASLEAIETSAFFL 
Hs CPT IA MEQQMQRILDNTSEPQPGEARLAALTAGDRVPWARCRQAYFGRGKNKQSLDAVEKAAFFV 
Hs CPT IB LEMQFQRILDDPSPPQPGEEKLAALTAGGRVEWAQARQAFFSSGKNKAALEAIERAAFFV 
 
Sa CPT I  TLDDEPQGYDP.AKTRSLDSYAKSLLHGKCYDRWFDKSFNLISYPNGKMGINAEHSWADA  476 
Om CPT I  SLDDEAHGYDP.DKLRSLDLYAKSLLHGKCYDRWFDKSFTLIAYKNGKLGVNAEHSWADA 
Hs CPT IA TLDETEEGYRSEDPDTSMDSYAKSLLHGRCYDRWFDKSFTFVVFKNGKMGLNAEHSWADA 
Hs CPT IB ALDEESYSYDPED.EASLSLYGKALLHGNCYNRWFDKSFTLISFKNGQLGLNAEHAWADA 
Sa CPT I  PIVGHMWEYVLATDCFHLGYTEEGHCKGDVNKGLPCPSRLQWQIPAECQEAIEKSYLSGK  536 
Om CPT I  PIIGHMWEYVLATDCFLLGYTEEGHCKGDINKGLPLPTKLQWDIPLECQEVIEESYMVAK 
Hs CPT IA QIVAHLWEYVMSIDSLQLGYAEDGHCKGDINPNIPYPTRLQWDIPGECQEVIETSLNTAN 
Hs CPT IB PIIGHLWEFVLGTDSFHLGYTETGHCLGKPNPALAPPTRLQWDIPKQCQAVIESSYQVAK 
Sa CPT I  QIADDVDFHGCLFTEFGKGLIKKCRTSPDAFIQLALQLAQFRDQGVFCLTYESSMTRMFR  596 
Om CPT I  VIADDVDFHGCLFDEFGKGLIKKSRTSPDAFIQLALQLAQFRDKGEFCLTYEASMTRMFR 
Hs CPT IA LLANDVDFHSFPFVAFGKGIIKKCRTSPDTFVQLALQLAHYKDMGKFCLTYEASMTRLFR 
Hs CPT IB ALADDVELYCFQFLPFGKGLIKKCRTSPDAFVQIALQLAHFRDRGKFCLTYEASMTRMFR 
Sa CPT I  DGRTETVRSCTSEAEAFVRAMEDAGATKAQRLALFRKAADKHQNMYRLAMTGSGIDRHLF  656 
Om CPT I  EGRTETVRSCTSESTAFVRAMEDKNTASAQKLDLFRKAADKHQNMYRLAMTGSGIDRHLF 
Hs CPT IA EGRTETVRSCTTESCDFVRAMVDPAQTVEQRLKLFKLASEKHQHMYRLAMTGSGIDRHLF 
Hs CPT IB EGRTETVRSCTSESTAFVQAMMEGSHTKADLRDLFQKAAKKHQNMYRLAMTGAGIDRHLF 
Sa CPT I  CLYIVSKYLGVDSPFLKKVLSEPWKLSTSQTPQQQLNLVDINKFPKYVGAGGGFGPVADD  716 
Om CPT I  CLYIMSKYLSIHSPFLKQVLSEPWRLSTSQTPQQQLNMVDIKKFPRYVGAGGGFGPVADD 
Hs CPT IA CLYVVSKYLAVESPFLKEVLSEPWRLSTSQTPQQQVELFDLENNPEYVSSGGGFGPVADD 
Hs CPT IB CLYLVSKYLGVSSPFLAEVLSEPWRLSTSQIPQSQIRMFDPEQHPNHLGAGGGFGPVADD 
Sa CPT I  GYGVSYIIVGENLITFHISCKFSSPDTDSYRFGQHIWKAMVDIQALFKPENNKKIVEHAK  776 
Om CPT I  GYGVSYIIIGENLITFHISSKFSSPETDSYRFGQNIRQAMLDIRALFDQKDKKEM 
Hs CPT IA GYGVSYILVGENLINFHISSKFSCPETDSHRFGRHLKEAMTDIITLFGLSSNSKK 
Hs CPT IB GYGVSYMIAGENTIFFHISSKFSSSETNAQRFGNHIRKALLDIADLFQVPKAYS 
 
 
Fig. 1. Alignment of the deduced amino acid sequence for the sea bream (Sa) and trout (Om) CPT1 (GenBank 
:AF327058) with those of the human (Hs) liver (1A, GenBank:L39211) and muscle (1B, GenBank:NM_004377) 
CPT1 isoforms. Residues identical in at least three of the sequences are shaded. Numbering on the right of the 
sequence corresponds to the sea bream residues.  
  
 
 
Fig. 2. Neighboring-joining tree (P-distance) for the protein sequence of CPT1 from sea bream and other vertebrate 
species. The tree was rooted to the human CPT2 (GenBank:NM_000098) protein sequence. Where available, 
GenBank accession numbers for the non-human sequences used to construct the tree are given following the species 
common name. Pufferfish (Puffer) sequences and some zebrafish sequences were derived by homology searches of 
the respective genomes (ENSEMBL Danio rerio Zv6; Takafugu rubripes FUGU4.0; www.ensembl.org/) against the 
sea bream CPT1 using TBLASTN. Proteins encoded by areas of genomic sequence with high homology to sea bream 
CPT1 were then derived using Wise2 (www.ebi.ac.uk/Wise2/). CHR or SCAF indicates the zebrafish chromosome 
number or pufferfish genomic scaffold for sequences derived this way. Distinct clades of the tree are shown to 
indicate the clustering of non-human sequences with either human CPT1A (GenBank:L39211), CPT1B 
(GenBank:NM_004377) or to show a fish-specific clade (1A-rel). Values at branch-points represent percentage 
frequencies for tree topology after 1000 iterations.  
 
3.3 Tissue mRNA expression of the sea bream CPT1. 
In order to examine the tissue mRNA expression of the sea bream CPT1 we initially 
performed the RNase protection assay on total RNA isolated from a variety of sea bream 
tissues.As shown in Figure 3A, the CPT1 transcripts are abundant in the red and white muscle 
tissues, as well as in the heart of sea bream. The CPT1 mRNA was also detected, albeit at lower 
level, in the fish brain. Weak CPT1 signals, at the limit of detection of the method, were 
observed in tissues such as kidney and liver, while no signal was detected in spleen, intestine, 
gills, and adipose tissue.  Quantitative real-time (Q-PCR) confirmed the results of RNase 
protection, with the mRNA expression of CPT1 being high in skeletal and cardiac muscle and 
low or very low in all other tissues tested (Fig. 3B). Thus, in accordance with the phylogenetic 
analysis the tissue mRNA expression analysis suggests that the identified sea bream cDNA 
encodes for a muscle-specific CPT1 isoform (CPT1B).  
 
 
 
Figure 3. CPT1B mRNA expression in the tissues of sea bream. A. RNase protection analysis in the liver (L), kidney 
(K), intestine (I), gills (G), heart (H), spleen (S), white muscle (W), red muscle (R), brain (B), and mesenteral adipose 
(A). Each lane contains the RNase-protected fragments from 8 µg of total RNA from each tissue incubated with 3 
fmoles of the radiolabeled CPT1B and β-actin riboprobes. A 1/8 fraction (1 µg) of the input total RNA used in the 
RNase protection assay is also shown and the main ribosomal RNAs (28 and 18S) are indicated. B. Quantitative real 
time-PCR (Q-PCR) analysis for the expression of CPT1B. Tissues are as in panel A. Data represent the mean (± SD) 
of independent experiments on tissues of at least three different fish. Values, normalized to the expression of the 
EF1a gene, are relative to the expression of CPT1B in the heart (H) of sea bream, which was arbitrarily set as one 
(H=1). 
 
3.4 CPT1B mRNA expression is regulated by the feeding status. 
To examine the possibility that CPT1 expression is also feeding status-dependent and 
PPAR-mediated in sea bream, we monitored the mRNA expression of CPT1 and of the three 
PPAR isotypes in muscle, heart, and liver tissue samples obtained at different time points 
following the feeding of fish. CPT1 mRNA expression was high in red muscle at 1 h post-
feeding and dropped significantly at 5 and 8 hrs post-feeding (Fig. 4). At 12 h post-feeding, 
CPT1 mRNA expression increased and reached initial levels at the 72 h time point. In this 
tissue, PPARα mRNA expression was significantly increased at 5 h post-feeding but decreased 
at later time points (Fig. 4). Red muscle PPARβ and PPARγ mRNA expression was not affected 
during the course of the experiment, with the exception of a significant increase in PPARγ 
transcript level at 72 h post-feeding (Fig. 4). 
In white muscle, CPT1 mRNA expression decreased gradually during the first 12 h 
post-feeding. At later time points, the expression of this gene increased significantly exceeding 
the 1 h value at the 72 h time point (Fig. 4). In this tissue, PPARα mRNA expression was 
extremely low as compared to that of the CPT1B and of the other two PPAR isotypes and 
exhibited a decreasing trend through the course of the experiment (Fig. 4). At 1 hr post feeding 
PPARβ was the most highly expressed gene, among the four studied, in the white muscle of sea 
bream. Similar to CPT1B, its expression decreased during the first 12 h post feeding but 
increased significantly at the 24 and 72 h time points (Fig. 4). White muscle PPARγ mRNA 
expression did not vary significantly during the course of the experiment, with the exception of 
elevated transcript levels observed at the 12 h time point (Fig. 4). 
As was the case in red muscle, CPT1B mRNA in sea bream heart was also relatively 
highly expressed and exhibited a similar trend in response to short-term fasting, i.e. its 
expression was decreased during the first 12 h and then gradually increased to equal or higher 
values of the initial time point (Fig. 4). Heart PPARα mRNA expression decreased significantly 
at 12 and 24 h, as compared to its levels at 3, 5, and 8 h following feeding (Fig. 4). No 
significant changes in PPARβ expression were observed in the sea bream heart during the 
course of the experiment, while the expression of PPARγ, albeit at relatively low levels, 
exhibited a significant increasing trend after the 8 h time point (Fig. 4). Finally, expression of 
CPT1B in the liver was very low during the first 12 h post-feeding but increased significantly at 
the 24 and 72 h time points (5 and 10 fold, respectively). PPARγ expression followed an 
opposite trend, with increased values during the first hours and decreased expression at later 
times (Fig. 4). 
From the above it is evident that the expression CPT1B and of the three PPAR isotypes 
is significantly regulated at the gene level in the tissues of sea bream in response to feeding and 
fasting. Furthermore, our results demonstrate that there is a positive and highly significant 
correlation between the expression of CPT1B and PPARβ in the white muscle (0.937, p < 
0.005) and liver (0.912, p < 0.005) of sea bream. In contrast, the expression pattern of either 
PPARα or PPARγ does not appear to follow the trend of CPT1B in any of the tissues tested 
(correlation coefficient<0.7, p>0.05, Supplementary Table 1). 
 
4. DISCUSSION 
In this report, we have identified and chracterized a cDNA from the muscle tissue of sea 
bream that encodes a protein with significant similarity to CPT1 proteins from mammalian and 
fish species. In contrast to the trout protein, where a 21 residue deletion has been observed at its 
amino-terminal region (Gutières et al., 2003), the sea bream protein aligns perfectly with the 
mammalian sequences in the corresponding region. Thus, the residues of the amino-terminal 
region established to be important for malonyl-CoA sensitivity in the liver (CPT1A) and muscle 
(CPT1B) isoforms of mammalian CPT1 (Shi et al., 1999, Shi et al., 2000) are conserved in the 
sea bream protein. Furthermore, the N-terminal domain (residues 1-150) of mammalian CPT1 
has been implicated in the insertion of the protein in the outer mitochondrial membrane (Cohen 
et al., 1998). The high identity between the sea bream and mammalian sequences in this region 
suggests that the elements responsible for membrane insertion are also conserved in the sea 
bream CPT1. In support of this, Von Heijne hydrophobicity analysis (Von Heijne, 1992) 
predicts the presence of two transmembrane helices spanning residues 50-80 and 100-136 in the 
sea bream sequence in good agreement with the predicted location of the transmembrane helices 
in the trout protein (Gutières et al., 2003). 
 
 Fig. 4. Post-prandial mRNA expression of CPT1B and PPAR isotypes in tissues of sea bream.  Expression of CPT1B 
and of the three PPAR isotypes in the sea bream red muscle (R), white muscle (WM), heart (H), and liver (L) at 
different time points following feeding was assessed by Q-PCR. Values are normalized to the expression of the EF1a 
gene and represent the mean (± SD) of independent experiments on tissues of five different fish.  Significant 
differences (p<0.05) between time points are indicated by letters, where a, b, c, d, e, and f correspond to the 1, 3, 5, 8, 
12, and 24 hrs time points, respectively. 
 
Of the functional motifs identified in the sea bream protein, both of the predicted 
carnitine acyltransferase sites (within residues 171–186 and 449–476, see also Fig. 1) are also 
found in corresponding positions in the mammalian liver and muscle isoforms. In contrast, from 
the two potential asparagine glycosylation sites at residues 312 and 367, only the first is 
conserved in the protein from other species. Interestingly, the potential tyrosine phosphorylation 
site at residue 191 is conserved only in the mammalian CPT1B. This site is also present in the 
originally reported trout protein (Gutières et al., 2003). Importantly, all of the above residues are 
located on the part of the protein exposed to the cytosol, according to the topology suggested for 
the mammalian CPT1 (Fraser et al., 1997). 
In mammalian CPT1, extensive mutagenesis studies have identified a number of 
residues in the C-terminal domain of the protein that are important for malonyl-CoA sensitivity 
and catalytic activity. Thus, in the rat liver enzyme, residues Glu-590, Arg-601, Glu-603, and 
Arg-606 are involved both in catalysis and malonyl-CoA sensitivity as mutations on these sites 
affect both properties (Treber et al., 2003, Napal et al., 2003). The above residues are conserved 
in the sea bream CPT1 (Glu-588, Arg-599, Glu-601, and Arg-604, respectively in Fig. 1), 
suggesting a common function in the properties of the protein. Furthermore, the residues 
proposed to form the catalytic triad of the mammalian muscle CPT1 isoform (CPT1B), i.e. Cys-
305, Asp-454, His-473 (Liu et al., 2005), are also conserved in the sea bream enzyme (Cys-303, 
Asp-453, His 471, respectively in Fig. 1). 
Very few previous reports have addressed CPT1 genes in fish species, despite their 
potential importance in determining utilisation of lipid in aquaculture diets. In an early study of 
a trout CPT1 cDNA it was suggested that a single CPT1 gene is present in trout, due to the 
ubiquitous presence of its transcripts in the tissues of the fish (Gutières et al., 2003). However, 
more recent evidence, including the catalytic examination of CPT1 activity in trout tissues, has 
indicated the presence of multiple CPT1 proteins (Morash et al., 2008). The sequence data 
available now supports the presence of multiple CPT1 genes in trout and several other studies 
have reported the measurement of various trout CPT1 mRNAs (Kolditz et al., 2008; Lansard et 
al., 2009; Morash et al., 2009; Plagnes-Juan et al., 2008; Polakof et al., 2010). The inclusion in 
the phylogenetic analysis performed in the present work of all know trout sequences, along with 
CPT1-like sequences from pufferfish and zebrafish, suggests that the sea bream protein is more 
closely related to the mammalian muscle CPT1 isoform, CPT1B. Furthermore, it reveals the 
potential complexity of the CPT1 system in fish, which it may be even more accentuated in 
species such as trout with a recently duplicated genome (Allendorf and Thorgaard, 1984). Thus 
we show that fish species possess multiple CPT1 genes, including a homlogue of mammalian 
CPT1B and up to four genes similar to mammalian CPT1A. Moreover, we show that two of the 
four known rainbow trout genes (GenBank: AF327058 and AJ606076, termed CPT1A and 
CPT1B, respectively in Kolditz et al., 2008) are likely to be duplicated CPT1B genes.  In 
zebrafish at least two distinct genes appear to encode each for a CPT1A-like isoform. In 
addition, zebrafish, pufferfish, and trout harbour in their genomes genes encoding a family of 
CPT1 proteins (CPT1A-rel in Fig. 2) that are distinct from the three known mammalian CPT1 
isoforms. The complexity of the system increases drastically if one considers the possibility of 
different splice variants of the above mRNAs and their corresponding proteins with potentially 
distinct functional roles and/or cellular targeting as has been previously suggested (Yu et al., 
1998b; Van der Leij et al., 2002). 
In accordance with the phylogenetic analysis, the tissue mRNA expression results 
indicate that the identified sea bream CPT1 is predominantly expressed in the muscle and heart 
tissues of sea bream with little or no expression in the other tissues tested. These results are very 
similar to those reported for the mRNA expression of a trout CPT1 (Morash et al., 2008). 
Therefore, we conclude that the identified cDNA encodes for a muscle-specific isoform of 
CPT1 and is therefore orthologous to the mammalian CPT1B. 
We have also demonstrated that the expression of the sea bream CPT1B isoform is 
regulated at the gene level according to feeding status. In general, our observations suggest that 
feeding results in a rapid post-prandial decrease in expression of CPT1B in white and red 
muscle and heart, followed by a return to pre-prandial levels at or after 24 h post-feeding. This 
pattern of expression/activity of CPT1B mRNA is likely to reflect the enzyme concentration 
required by the tissue to meet its energy needs. Thus, synthesis of new enzyme/increased 
activity 24 hours after last feeding appears to be required when the substrates, i.e. fatty acyl-
CoAs, are not available from dietary sources but are derived from the mobilization of the fat 
reserves of the fish. This mobilization is related to the large increase of CPT1B mRNA in liver 
after 24 h, reflecting the role of this tissue in co-ordinating the response to fasting. Measurement 
of a trout CPT1B-like mRNA (GenBank: AF606076) showed a decrease in hepatic expression 
following refeeding after 5 days fasting (Lansard et al, 2010), and this CPT1B-like and another 
closely related trout CPT1B- like mRNA (GenBank: AF327058) were both reduced after insulin 
treatment of fish which were not fed for 48 hours previously (Plagnes-Juan, et al., 2008). These 
effects are generally in agreement with our results for sea bream, and indicate that fish hepatic 
CPT1B is increased as food supply is reduced, and decreased post-prandially. These dwon-
regulating effects may be mediated by rises in insulin caused by feeding. Down-regulation of 
CPT1B-like mRNA in trout muscle after chronic or acute insulin treatment has also been 
recently demonstrated (Polakof et al., 2010). 
Although insulin is a clear candidate for mediating reduced CPT1B expression, PPARs 
have been shown to up-regulate CPT1 gene expression in mammals (Baldán et al., 2004, Gilde 
et al., 2003, Mescaró et al., 1998). The parallel examination of the expression of the three 
PPAR isotypes in this post-prandial experiment revealed a positive and strong correlation 
between the expression pattern of CPT1B and that of PPARβ in the white muscle and also the 
liver of sea bream. Thus, in liver the mRNA expression of PPAR was as previously reported 
(Leaver et al., 2005; Diaz et al., 2007), i.e. its expression decreased during the first 5 hrs post 
feeding, then gradually increased to reach or surpass the initial values at the 24 and 72 h time 
points. The same pattern was also observed for PPARβ in the sea bream white muscle, 
following closely the expression of CPT1B. In contrast, the expression pattern of CPT1B was 
not related to that of either PPARα or PPARγ in any of the sea bream tissues tested. These 
results suggest that PPARβ, but not PPARα or PPARγ, is involved in the regulation of 
expression of CPT1B in sea bream tissues in response to feeding and fasting. Relevant to this, 
PPARβ has been shown to up-regulate lipid oxidation in the muscle of fasting mammals, a 
process that also involves the increased expression of CPT1B (de Lange et al., 2008). 
To our knowledge, this is the first report that examines the post-prandial CPT1 mRNA 
expression in a fish species in a timedependent manner and it complements our previous 
observations on the post-prandial expression of the three PPAR isotypes in sea bream (Leaver et 
al., 2005; Diez et al., 2007). Most studies on the mRNA expression and/or activity of CPT1 
isoforms in fish concern the response to either dietary or hormonal treatments (Kolditz et al., 
2008; Lansard et al., 2009; Leaver et al., 2006; Morash et al., 2009; Plagnes-Juan et al., 2008; 
Polakof et al., 2010). In the few studies where the expression of PPAR isotypeswas studied in 
parallel to that of CPT1, no clear association between the expression of the CPT1 and PPAR 
genes was observed (Kolditz et al., 2008; Leaver et al., 2006; Morash et al., 2009). 
Clearly, mRNA expression data alone are not sufficient to indicate changes in CPT1 
catalytic activity or to exclude the involvement of PPARα and/or PPARγ in the regulation of 
this gene in the tissues of sea bream. Enhancement or repression of PPAR isotype expression is 
not a necessary prerequisite for corresponding induction/repression of their target genes. The 
transcriptional activity of these receptors is also subject to the tissue-specific availability of 
coactivators or corepressors and on phosphorylation state (Desvergne and Wahli, 1999, Xu et 
al., 1999). Definite conclusions concerning the involvement of particular, if any, PPAR isotypes 
in the transcriptional regulation and activity of CPT1 in sea bream, or other fish speciesmust 
await the characterization of other identified CPT1 genes, the promoter structures of thesegenes 
and the catalytic activities of their products 
 
ACKNOWLEDGMENTS 
This work was supported in part by the European Commission (Project Number Q5RS-
2000-30360). E.B. was supported in part by an OECD fellowship. The sequence described 
herein has been deposited to the EMBL/GenBank databases under accession no. DQ866821.       
 
Appendix A. Supplementary data 
Supplementary data associated with this article can be found, in the online version, at 
doi:10.1016/j.cbpb.2010.06.004.  . 
 
5. REFERENCES 
Allendorf, F.W., Thorgaard, G., 1984. Tetraploidy and the evolution of salmonid fishes. In: 
Turner, B.J. (Ed.), The Evolutionary Genetics of Fishes. Plenum Press, New York, pp. 
1–53. 
 Baldán, A., Relat, J., Marrero, P.F., Haro, D., 2004, Functional interaction between peroxisome 
proliferator-activated receptors-α and Mef-2C on human carnitine palmitoyltransferase 
1β (CPT1β) gene activation. Nucleic Acids Res. 32, 4742-4749. 
Boukouvala, E., Antonopoulou, E., Favre-Krey, L., Diez, A., Bautista, J.M., Leaver, M.J., 
Tocher, D.R., Krey, G., 2004, Molecular characterization of three peroxisome 
proliferators-activated receptors from the sea bass (Dicentrarchus labrax). Lipids 39, 
1085-1092. 
 Brandt, J.M., Djouadi, F., Kelly, D.P., 1998, Fatty acids activate transcription of the muscle 
carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome 
proliferators-activated receptor α. J. Biol. Chem. 273, 23786-23792. 
Britton, C.H., Schultz, R.A., Zhang, B., Esser, V., Foster, D.W., McGarry, J.D., 1995, Human 
liver mitochondrial carnitine palmitoyltransferase I: Characterization of its cDNA and 
chromosomal localization and partial analysis of the gene. Proc. Natl. Acad. Sci. U.S.A. 
92, 1984-1988. 
Cohen, I., Kohl, C., McGarry, J.D., Girard, J., Prip-Buus, C., 1998, The N-terminal domain of 
rat liver carnitine palmitoyltransferase 1 mediates import into the outer mitochondrial 
membrane and is essential for activity and malonyl-CoA sensitivity. J. Biol. Chem. 273, 
29896-29904. 
Cook, G.A., Edwards, T.L., Jansen, M.S., Bahouth, S.W., Wilcox, H.G., Park, E.A., 2001, 
Differential regulation of carnitine Palmitoyltransferase-1 gene Isoforms (CPT-1a and 
CPT-1b) in the Rat Heart. J. Mol. Cell. Cardiol. 33, 317–329. 
De Lange, P., Lombardi, A., Silvestri, E., Goglia, F., Lanni, A., Moreno, M., 2008, Peroxisome 
Proliferator-Activated Receptor Delta: A Conserved Director of Lipid Homeostasis 
through Regulation of the Oxidative Capacity of Muscle. PPAR Res. Article ID 
172676.  
 Desvergne, B., Ijpenberg, A., Devchand, P.R., Wahli, W., 1998, The peroxisome proliferator-
activated receptors at the cross-road of diet and hormonal signalling. J. Ster. Biochem. 
Mol. Biol. 65, 65-74. 
 Desvergne, B., Wahli, W., 1999, Peroxisome proliferator-activated receptors: nuclear control of 
metabolism. Endocr. Rev. 20, 649-688. 
Diez, A., Menoyo, D., Pérez-Benavente, S., Calduch-Giner, J.A., Vega-Rubin de Celis, S., 
Obach, A., Favre-Krey, L., Boukouvala, E., Leaver, M.J., Tocher, D.R., Pérez-Sanchez, 
J., Krey, G., Bautista, J.M., 2007. Conjugated linoleic acid affects lipid composition, 
metabolism, and gene expression in gilthead sea bream (Sparus aurata L). J. Nutr. 137, 
1363–1369. 
Esser, V., Brown, N.F., Cowan, A.T., Foster, D.W., McGarry, J.D., 1996, Expression of a 
cDNA isolated from rat brown adipose tissue and heart identifies the product as the 
muscle isoform of carnitine palmitoyltransferase I (M-CPT I). J. Biol. Chem. 271, 
6972-6977. 
Fraser, F., Corstorphine, C.G., Zammit, V.A., 1997, Topology of carnitine palmitoyltransferase 
I in the mitochomdrial outer membrane. Biochem. J. 323, 711-718. 
Gao, X.F., Chen, W., Kong, X.P., Xu, A.M., Wang, Z.G., Sweeney, G., Wu, D., 2009, 
Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a 
high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle 
glucose uptake. Diabetologia 52, 912–920. 
Gilde, A.J., van der Lee, K.A.J.M., Willemsen, P.H.M., Chinetti, G., van der Leij, F.R., van der 
Vusse, G.J., Staels, B., van Bilsen, M., 2003, Peroxisome proliferators-activated 
receptor (PPAR) α and PPARβ/δ but not PPARγ, modulate the expression of genes 
involved in cardiac lipid metabolism. Circ. Res. 92, 518-524. 
Gutières, S., Damon, M., Panserat, S., Kaushik, S., Médale, F., 2003, Cloning and tissue 
distribution of a carnitine palmitoyltransferase I gene in rainbow trout (Oncorhynchus 
mykiss). Comp. Biochem. Physiol. B 135, 139-151. 
 Kersten, S., Seydoux, J., Peters, J.M., Gonzales, F.J., Desvergne, B., Wahli, W., 1999, 
Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. 
J. Clin. Invest. 103, 1489-1498. 
Kolditz, C., Borthaire, M., Richard, N., Corraze, G., Panserat, S., Vachot, C., Lefevre, F., 
Medale, F., 2008. Liver and muscle metabolic changes induced by dietary energy 
content and genetic selection in rainbow trout (Oncorhynchus mykiss). Am. J. Physiol. 
Regul. Integr. Comp. Physiol. 294, 1154–1164. 
Kumar, S., Tamura, K., Jakobsen, I.B., Nei, M., 2001, MEGA2: molecular evolutionary 
genetics analysis software. Bioinformatics 17, 1244-1245. 
Lansard, M., Panserat, S., Seiliez, I., Polakof, S., Plagnes-Juan, E., Geurden, I., Médale, F., 
Kaushik, S., Corraze, G., Skiba-Cassy, S., 2009. Hepatic protein kinase B (Akt)-target 
of rapamycin (TOR)-signalling pathways and intermediary metabolism in rainbow trout 
(Oncorhynchus mykiss) are not significantly affected by feeding plant-based diets. Br. 
J. Nutr. 102, 1564–1573. 
Leaver, M.J., Boukouvala, E., Antonopoulou, E., Diez, A., Favre-Krey, L., Ezaz, M.T., 
Bautista, J.M., Tocher, D.R., Krey, G., 2005, Three peroxisome proliferators-activated 
receptor isotypes from each of two species of marine fish. Endocrinology 146, 3150-
3162. 
Leaver, M.J., Bautista, J.M., Björnsson, B.T., Jönsson, E., Krey, G., Tocher, D.R., Torstensen, 
B.E., 2008, Towards Fish Lipid Nutrigenomics: Current State and Prospects for Fin-
Fish Aquaculture. Rev. Fish. Sci. 161, 71-92. 
Leone, T., Weinheimer, C.J.,  Kelly, D.P., 1999, A critical role for the peroxisome proliferators-
activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse 
as a model of fatty acid oxidation disorders. Proc. Natl. Acad. Sci. U.S.A. 96, 7473-
7478. 
Liu, H.Y., Zheng, G., Treber, M., Dai, J., Woldergiorgis, G., 2005, Cysteine-scanning 
mutagenesis of muscle carnitine palmitoyltransferase I reveals a single cysteine residue 
(Cys-305) is important for catalysis. J. Biol Chem. 280, 4524-4531. 
McGarry, J.D., Brown, N.F., 1997, The mitochondrial carnitine palmitoyltransferase system. 
From concept to molecular analysis. Eur. J. Biochem. 244, 1-14. 
Mescaró, C., Acosta, E., Ortiz, J.A., Marrero, P.F., Hegardt, F.G., Haro, D., 1998, Control of 
human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome 
proliferator-activated receptor. J. Biol. Chem. 273, 8560-8563. 
Morash A.J., Kajimura M, McClelland G.B., 2008, Intertissue regulation of carnitine 
palmitoyltransferase I (CPTI): Mitochondrial membrane properties and gene expression 
in in rainbow trout (Oncorhynchus mykiss), Biochem. Biophys. Acta 1778, 1382-1389. 
Morash A.J., Kajimura M, McClelland G.B., 2009, Effect of dietary fatty acid composition on 
the regulation of carnitine palmitoyltransferase (CPT) I in rainbow trout (Oncorhynchus 
mykiss). Comp. Biochem. Physiol. B 152, 85-93. 
Napal, L., Dai, J., Treber, M., Haro, D., Marrero, P.F., Woldegiorgis, G., 2003, A single amino 
acid change (substitution of the conserved Glu-590 with alanine) in the C-terminal 
domain of rat liver carnitine palmitoytransferase I increases its malonyl-CoA sensitivity 
close to that observed with the muscle isoform of the enzyme. J. Biol. Chem. 278, 
34084-34089. 
 Pfaffl, M.W., 2001, A new mathematical model for relative quantification in real-time RT-
PCR. Nucl. Acids Res. 29, e45 
Plagnes-Juan, E., Lansard, M., Seiliez, I., Medale, F., Corraze, G., Kaushik, S., Panserat, S., 
Skiba-Cassy, S., 2008. Insulin regulates the expression of several metabolismrelated 
genes in the liver and primary hepatocytes of rainbow trout (Oncorhynchus mykiss). J. 
Exp. Biol. 211, 2510–2518 
Polakof, S., Médale, F., Skiba-Cassy, S., Corraze, G., Panserat, S., 2010. Molecular regulation 
of lipid metabolism in liver and muscle of rainbow trout subjected to acute and chronic 
insulin treatments. Domest. Anim. Endocrinol. 39, 26–33. 
Price, N.T., van der Leij, F.R., Jackson, V.N., Corstophine, C.G., Thomson, R., Sorensen, A., 
Zammit, V.A., 2002, A novel brain –expressed protein related to carnitine 
palmitoyltransferase I. Genomics 80, 434-442. 
Shi, J., Zhu, H., Arvidson, D.N., Woldegiorgis, G., 1999, A single amino acid change 
(substitution of glutamate 3 with alanine) in the N-terminal region of rat liver carnitine 
palmitoyltransferase I abolishes malonyl-CoA inhibition and high affinity binding. J. 
Biol. Chem. 274, 9421-9426. 
Shi, J., Zhu, H., Arvidson, D.N., Woldegiorgis, G., 2000, The first 28 N-terminal amino acid 
residues of human heart muscle carnitine palmitoyltransferase I are essential for 
malonyl CoA sensitivity and high-affinity binding. Biochem. 39, 712-717. 
Swofford, D.L., 2000, Phylogenetic analysis using parsimony (and other methods), Version 4b. 
Sinauer Asoociates, Sunderland, Massachusetts. 
Treber, M., Dai, J., Woldegiorgis, G., 2003, Identification by mutagenesis of conserved arginine 
and glutamate residues in the C-terminal domain of rat liver carnitine 
palmitoyltransferase I that are important for catalytic activity and malonyl-CoA 
sensitivity. J. Biol. Chem. 278, 11145-11149. 
van der Leij, F.R., Cox, K.B., Jackson, V.N., Huijkman, N.C.A., Bartelds, B., Kuipers, J.R.G., 
Dijkhuizen, T., Terpstra, P., Wood, P.A., Zammit, V.A., Price, N.T., 2002, Structural 
and functional genomics of the CPT1B gene for muscle-type carnitine 
palmitoyltransferase I in mammals. J. Biol. Chem. 277, 26994-27005. 
Von Heijne, G., 1992, Membrane protein structure prediction. Hydrophobicity analysis and the 
positive-inside rule. J. Mol. Biol. 225, 487-494. 
Xu, L., Glass, C.K., Rosenfeld, M.G., 1999, Coactivator and corepressor complxes in nuclear 
receptor function. Curr. Opin, Genet. Dev. 9, 140-147. 
Yu, G.S., Lu, Y.C., Gulick, T., 1998, Co-regulation of tissue-specific alternative human 
carnitine palmitoyltransferase Iβ gene promoters by fatty acid enzyme substrate. J. Biol. 
Chem. 273, 32901-32909. 
Yu, G.S., Lu, Y.C., Gulick, T., 1998, Expression of novel isoforms of carnitine 
palmitoyltransferase I (CPT-1) generated by alternative splicing of the CPT-1 beta gene. 
Biochem. J. 334, 225-31. 
